Key facts
- It has raised $1.6M; the latest was Early Stage VC in Jun 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for BesTop Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for BesTop Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BesTop Medical
Manufacturer of single-cell tumor diagnostic instruments and reagents aims to overcome the challenge of tumor heterogeneity and advance personalized precision medicine. The company's offerings feature high-throughput single-cell sequencing instruments, diagnostic reagents, and molecular detection analysis systems, supported by core expertise in omics technologies, bioinformatics, and clinical translation. With R&D centers and branches across major cities in China, the company integrates advanced technology, strong technical services, and international standards, helping researchers and clinicians benefit from more accurate detection of tumor heterogeneity and immune diversity, enabling effective, economical, and personalized cancer diagnosis and treatment.
- Sector
- Healthcare
- HQ
- Tianjin, China
- Founded
- 2020
- Website
- bestopmed.com/
- Ownership
- Privately Held (backing)
BesTop Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BesTop Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BesTop Medical in its N-PORT filings yet. We sweep new filings monthly.